Macleods Pharmaceuticals Ltd is a prominent Indian pharmaceutical company, ranked 7th in the sector, specialising in the development, manufacturing, and marketing of a diverse portfolio of pharmaceutical products. The company has established its own research and development facilities, bioequivalence centres, and manufacturing sites for active pharmaceutical ingredients (APIs) and finished dosage forms. With approvals from regulatory authorities such as the USFDA and MHRA, Macleods Pharmaceuticals offers a range of therapeutic products including cardiovascular, central nervous system, anti-diabetic, anti-HIV, anti-TB, anti-asthmatic, and anti-malarial medications. With a strong international presence across 110 countries and subsidiaries in the USA, UK, Spain, South Africa, Ukraine, and Kazakhstan, Macleods is committed to providing innovative and quality healthcare solutions worldwide.

Services include:
- APIs (Active Pharmaceutical Ingredients)
- Contract Development and Manufacturing (CDMO)
- Finished Dosage Form (FDF) Supply
- EU Marketing Authorisations
- Out-licensing for US/EU CTD

Macleods Pharmaceuticals Ltd is dedicated to enhancing global healthcare through its extensive range of pharmaceutical products and services. For more information, please visit macleodspharma.com.